Physician Assistant Program year 2022 Source: CMS Open Payments, 2026 publication

Justine Gadd

Physician Assistant Barre, VT Physician Assistant

NPI 1669499430 CMS profile 10697554

246 Granger Rd Ste 2, Barre, VT 05641

Open in the dashboard

General payments

$23

1 record reported · program year 2022

Research payments

$0

Paid to them · None reported · program year 2022

Ownership & investment interest

$0

None reported

Through program year 2022, Justine Gadd of Barre, VT is reported in the CMS Open Payments database as having received $23 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 7th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2022 General $23 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justine Gadd
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Justine Gadd were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Justine Gadd Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $23 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program year 2022
  1. Pfizer Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program year 2022
  1. Education $23 1 payment
Products named General payments · program year 2022
  1. MYFEMBREE $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

279

Median for Physician Assistant: 241

Drug cost

$13,942

Median for Physician Assistant: $4,110

Branded share of claims

3.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 11 $10,403
Omeprazole Generic 43 $578
Levothyroxine Sodium Generic 30 $404
Gabapentin Generic 14 $386
Atorvastatin Calcium Generic 20 $329
Famotidine Generic 16 $299
Pravastatin Sodium Generic 11 $297
Mirtazapine Generic 17 $291
Losartan Potassium Generic 25 $289
Metoprolol Succinate Generic 15 $200

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Vermont

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record